The Iowa Court of Appeals has affirmed the denial of Daniel Maurice Claybon's sixth postconviction relief (PCR) application. This decision, filed on July 8, 2026, affects Claybon, who has been attempting to overturn his 1990 first-degree murder conviction. The court ruled that Claybon's claims were barred by the statute of limitations, as he filed his application too late.
Claybon was convicted in 1990 for the shooting death of J.W. He appealed his conviction, but the Iowa Court of Appeals upheld the jury's decision in 1992. Over the years, Claybon has filed multiple PCR applications, totaling six, all of which have been denied. His latest attempt was based on newly discovered evidence, which he claimed justified his late filing.
The dispute centers around the validity of the evidence Claybon presented to support his claim. In his sixth PCR application, he asserted that two witnesses from his original trial had recanted their testimony. To support this assertion, Claybon provided an affidavit from one witness, M.H., and unsworn notes from a private investigator regarding the other witness, T.G. However, the State of Iowa contested the reliability of this evidence and moved for summary disposition, arguing that Claybon's claims did not meet the necessary legal standards.
The Iowa District Court for Black Hawk County, presided over by Judge Linda M. Fangman, reviewed the case. The court ultimately sided with the State, concluding that Claybon's evidence did not qualify as newly discovered evidence under Iowa law. The court stated that the private investigator's notes were "not reliable enough to warrant more consideration." Additionally, the court found that Claybon failed to demonstrate that M.H.'s affidavit met the legal requirements for a newly discovered evidence claim.
The court ruled, "The district court properly concluded that Claybon’s claims were barred by the statute of limitations in section 822.3." This decision highlights the importance of adhering to legal timeframes when filing PCR applications. The court noted that a full opinion was unnecessary, as the parties had already received sufficient analysis from the district court's ruling.
This ruling has significant implications for Claybon and others in similar situations. The court's affirmation reinforces the strict nature of the statute of limitations for PCR actions in Iowa. It emphasizes that even claims of newly discovered evidence must be presented within the designated timeframe to be considered valid. This could deter future applicants from pursuing similar claims if they are unable to meet the legal requirements for timely filing.
Going forward, Claybon's options appear limited. The court's ruling can be appealed to the Iowa Supreme Court, but it remains uncertain whether he will pursue this route. There are no related cases pending that could affect the outcome of his situation. Claybon's long history of unsuccessful PCR applications may complicate any further attempts to overturn his conviction.